According to ASCCP guidelines, should a 42-year-old woman with three consecutive annual Pap tests showing low-grade squamous intraepithelial lesion (LSIL) and negative high-risk human papillomavirus (HPV) results undergo colposcopy?

No, colposcopy is not required for this patient

For a 42-year-old woman with three consecutive annual Pap tests showing LSIL and negative HPV results, the 2019 ASCCP guidelines recommend repeat HPV testing (with or without concurrent Pap) in 1 year rather than immediate colposcopy 1.

Key Guideline Principles

The 2019 ASCCP risk-based management guidelines fundamentally changed the approach to HPV-negative LSIL. The critical distinction is whether the patient had negative screening results with HPV testing or cotesting within the previous 5 years 1.

Why Colposcopy Can Be Deferred

• Risk stratification by age and HPV status: Older women (≥30 years) with HPV-negative LSIL have significantly lower risk for CIN3+ compared to HPV-positive cases 2
• The 2012 guidelines stated explicitly: "Because the risk for CIN3+ decreases with age, older women with HPV-negative LSIL may be managed the same as those with HPV-negative ASC-US" 2
• The 2019 guidelines formalized this: When LSIL is preceded by negative screening HPV test or cotest within the past 5 years, follow-up in 1 year is recommended instead of colposcopy 1

Critical Caveat

This deferral only applies if the negative HPV tests were performed for screening purposes, not for surveillance of previous abnormalities 1. If these three annual tests were done as surveillance for a prior high-grade lesion (CIN 2/3, HSIL, ASC-H, AGC, or AIS), then colposcopy would still be warranted 1.

Management Algorithm for This Patient

1. Verify screening context: Confirm these were screening tests, not surveillance for prior abnormalities
2. If screening tests: Repeat HPV test with or without concurrent Pap in 1 year 1
3. At 1-year follow-up:
   • If cytology abnormal OR HPV positive → refer to colposcopy 1
   • If both negative → return to routine screening 1

Common Pitfalls to Avoid

• Don't apply 2012 guidelines: The 2012 guidelines recommended immediate colposcopy for all LSIL regardless of HPV status 3. The 2019 guidelines supersede this for cases with recent negative screening
• Don't ignore the 5-year window: The protective effect of negative screening only applies if performed within the previous 5 years 1
• Don't confuse screening with surveillance: Negative HPV tests done during surveillance for previous abnormalities do not reduce risk sufficiently to defer colposcopy 1

Supporting Evidence

Research data support this conservative approach. Studies show that HPV-negative LSIL carries substantially lower risk for high-grade disease, with cumulative incidence of CIN2+ around 5-13% compared to 19-54% for HPV-positive LSIL 4, 5, 6. The negative predictive value of HPV testing in LSIL is approximately 98-99% 7, 8.